3/27
07:38 am
syrs
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Low
Report
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/27
07:30 am
syrs
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Medium
Report
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
3/25
07:05 am
syrs
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial [Yahoo! Finance]
Low
Report
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial [Yahoo! Finance]
3/25
07:00 am
syrs
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
Low
Report
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
3/20
07:00 am
syrs
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
Low
Report
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
3/12
11:02 pm
syrs
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/29
03:07 pm
syrs
Activist investor Jeff Ubben to join Bayer’s supervisory board [FT.com - Mergermarket]
Low
Report
Activist investor Jeff Ubben to join Bayer’s supervisory board [FT.com - Mergermarket]
2/27
07:00 am
syrs
Syros to Participate in TD Cowen 44th Annual Health Care Conference
Medium
Report
Syros to Participate in TD Cowen 44th Annual Health Care Conference
2/27
05:36 am
syrs
Investors in Syros Pharmaceuticals (NASDAQ:SYRS) have seen respectable returns of 99% over the past year [Yahoo! Finance]
Medium
Report
Investors in Syros Pharmaceuticals (NASDAQ:SYRS) have seen respectable returns of 99% over the past year [Yahoo! Finance]
2/16
01:08 am
syrs
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/13
07:34 pm
syrs
Treadwell Announces the Formation and Members of Scientific Advisory Board [Yahoo! Finance]
Low
Report
Treadwell Announces the Formation and Members of Scientific Advisory Board [Yahoo! Finance]
2/8
04:09 am
syrs
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
1/31
10:03 pm
syrs
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
1/23
10:06 pm
syrs
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
1/19
12:28 pm
syrs
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why [Yahoo! Finance]
Low
Report
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why [Yahoo! Finance]
1/18
01:17 pm
syrs
Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice [Yahoo! Finance]
Low
Report
Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice [Yahoo! Finance]
1/17
10:59 am
syrs
Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Low
Report
Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
1/16
01:35 pm
syrs
What Makes Syros Pharmaceuticals, Inc. (SYRS) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes Syros Pharmaceuticals, Inc. (SYRS) a New Buy Stock [Yahoo! Finance]
1/16
11:36 am
syrs
Wall Street Analysts Predict a 199.31% Upside in Syros Pharmaceuticals, Inc. (SYRS): Here's What You Should Know [Yahoo! Finance]
Low
Report
Wall Street Analysts Predict a 199.31% Upside in Syros Pharmaceuticals, Inc. (SYRS): Here's What You Should Know [Yahoo! Finance]
1/14
03:54 am
syrs
Syros Pharmaceuticals: Rising Despite Dilution, A Must Look [Seeking Alpha]
Low
Report
Syros Pharmaceuticals: Rising Despite Dilution, A Must Look [Seeking Alpha]
1/8
07:12 am
syrs
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene [Yahoo! Finance]
Medium
Report
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene [Yahoo! Finance]
1/8
07:00 am
syrs
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene
Medium
Report
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene